Hyaluronidase / pertuzumab / trastuzumab User Reviews & Ratings
Brand names: Phesgo
Hyaluronidase / pertuzumab / trastuzumab has an average rating of 8.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Breast Cancer | 1 reviews for Breast Cancer | 82 medications |
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about hyaluronidase / pertuzumab / trastuzumab
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- En español
Patient resources
- Hyaluronidase, pertuzumab, and trastuzumab drug information
- Pertuzumab, trastuzumab, and hyaluronidase-zzxf (Advanced Reading)
For Breast Cancer "Phesgo seems to work so far. I have been on this drug for four years, shot given every 3 weeks. Eight-year survivor of stage IV Her 2+. Every so often, side effects pop up. Fatigue, gastrointestinal, feet and hands tingle/numbness, skin problems, and heavier breathing at times. The benefits outweigh the negatives. Most of these side effects are inconvenient, having to spend time at various doctor's offices when dealing with these issues, but I don't think I would be here now without this, or the other drugs used in treating my cancer. Another positive regarding this drug is that it is injected into the thigh. It takes 5 minutes to administer. Much better than having two infusions that take at least 1 1/2 hours."